• About
  • HS
  • ELN28
  • Team
  • Talk To Us
  • News
  • Publications

VNARs: An Ancient and Unique Repertoire of Molecules That Deliver Small, Soluble, Stable and High Affinity Binders of Proteins

by ElasmoAdm1n | Jan 6, 2026 | Publications

Caroline Barelle, Andy Porter Antibodies 2015, 4(3), 240-258; doi:10.3390/antib4030240 Read now… (Journal)

Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy

by ElasmoAdm1n | Jan 6, 2026 | Publications

Smyth P, Ferguson L, Burrows JF, Burden RE, Tracey SR, Herron ÚM, Kovaleva M, Williams R, Porter AJ, Longley DB, Barelle CJ and Scott CJ Front. Pharmacol. 2023 14:1296567. doi: 10.3389/fphar.2023.1296567 Read now…

Structural insights and biomedical potential of IgNAR scaffolds from sharks

by ElasmoAdm1n | Jan 6, 2026 | Publications

Zielonka S, Empting M, Grzeschik J, Könning D, Barelle CJ, Kolmar H. MAbs. 2015; 7(1):15-25. doi: 10.4161/19420862.2015.989032. Read now… (PubMed)

Functionalization of polymeric nanoparticles with targeting VNAR ligands using vinyl sulfone conjugation

by ElasmoAdm1n | Jan 6, 2026 | Publications

Leach, A., Finnegan, M., Machado, M.S., Ferguson, L., Steve, J., Smyth, P., Porter, A., Barelle, C., Themistou, E. & Scott, C. J. J. Mater. Chem. 2023 11, 4181-4190. doi: https://doi.org/10.1039/D2TB01985J Read now…

Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis

by ElasmoAdm1n | Jan 6, 2026 | Publications

Marina Kovaleva, Katherine Johnson, John Steven, Caroline Barelle and Andrew Porter. Front Immunol. 2017 Sep 25;8:1121. doi: 10.3389/fimmu.2017.01121. eCollection 2017. Read now… (PubMed)

Phage Display Derived IgNAR V Region Binding Domains for Therapeutic Development

by ElasmoAdm1n | Jan 6, 2026 | Publications

Ubah OC, Barelle CJ, Buschhaus MJ,Porter AJ. Curr Pharm Des. 2016;22(43):6519-6526. doi: 10.2174/1381612822666160907091708. Review. Read now… (PubMed)
« Older Entries
Next Entries »

Recent Posts

  • Elasmogen Ltd is pleased to announce the appointment of Dr Suhail Nurbhai as Chief Medical Officer
  • Elasmogen and Intract Enter License Agreement for Soteria® and Phloral® Technologies
  • Elasmogen Researcher receives prestigious £2m fellowship to help establish him as future UK bioscience leader
  • Elasmogen announces a panel of novel, potent, anti-Covid-19 therapeutic candidates identified through collaboration with U.S. research partners
  • Elasmogen announces grants of 2 new VNAR and soloMER patent families

Recent Comments

No comments to show.
  • Follow

TALK TO US

PRIVACY POLICY

Elasmogen Ltd
Liberty Building
Foresterhill Health Campus
Foresterhill Rd
Aberdeen AB25 2ZP

Visit Us

Elasmogen Ltd

Liberty Building
Foresterhill Health Campus
Foresterhill Rd
Aberdeen AB25 2ZP

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
►
Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
None
Powered by